Correlation Between Episurf Medical and Oncopeptides

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Episurf Medical and Oncopeptides at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Episurf Medical and Oncopeptides into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Episurf Medical AB and Oncopeptides AB, you can compare the effects of market volatilities on Episurf Medical and Oncopeptides and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Episurf Medical with a short position of Oncopeptides. Check out your portfolio center. Please also check ongoing floating volatility patterns of Episurf Medical and Oncopeptides.

Diversification Opportunities for Episurf Medical and Oncopeptides

-0.19
  Correlation Coefficient

Good diversification

The 3 months correlation between Episurf and Oncopeptides is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding Episurf Medical AB and Oncopeptides AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncopeptides AB and Episurf Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Episurf Medical AB are associated (or correlated) with Oncopeptides. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncopeptides AB has no effect on the direction of Episurf Medical i.e., Episurf Medical and Oncopeptides go up and down completely randomly.

Pair Corralation between Episurf Medical and Oncopeptides

Assuming the 90 days trading horizon Episurf Medical AB is expected to generate 1.24 times more return on investment than Oncopeptides. However, Episurf Medical is 1.24 times more volatile than Oncopeptides AB. It trades about -0.09 of its potential returns per unit of risk. Oncopeptides AB is currently generating about -0.15 per unit of risk. If you would invest  18.00  in Episurf Medical AB on September 12, 2024 and sell it today you would lose (5.00) from holding Episurf Medical AB or give up 27.78% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Episurf Medical AB  vs.  Oncopeptides AB

 Performance 
       Timeline  
Episurf Medical AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Episurf Medical AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's forward indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Oncopeptides AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oncopeptides AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Episurf Medical and Oncopeptides Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Episurf Medical and Oncopeptides

The main advantage of trading using opposite Episurf Medical and Oncopeptides positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Episurf Medical position performs unexpectedly, Oncopeptides can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncopeptides will offset losses from the drop in Oncopeptides' long position.
The idea behind Episurf Medical AB and Oncopeptides AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Share Portfolio
Track or share privately all of your investments from the convenience of any device
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like